Berkeley Entrepreneurs Forum

August 30, 2007 Program

• Elevator Pitch Session
• Venture Capital Term Sheet Survey Results: Fenwick & West
• National Venture Capital Association Money Tree Report: PriceWaterhouse Coopers
• Venture Capital Panel Discussion

Thursday, August 30, 2007

6:30 - 8:30 PM

Arthur Andersen Auditorium
Haas School of Business

To Register     Parking Information

Join the Forum for our inaugural program of our 07-08 season where we will feature our annual assessment of the venture financing environment and its effects on new ventures. The program will start with an assessment of last years projections of the markets followed by a comparison to the current market. A panel of distinguished venture capitalists will discuss trends, including hot sectors, and developments in venture valuations and deal terms.

Our panel will include:

Brian Atwood specializes in biotechnology investing at Versant Ventures, which he co-founded after spending four years at Brentwood Venture Capital, where as a general partner he led investments in biotechnology, pharmaceuticals, and bioinformatics. He also has more than 15 years of operating experience in the biotechnology industry, with emphasis on therapeutic products, devices, diagnostics, and research instrumentation. Prior to launching his career in venture capital, Brian was founder, president, and CEO of Glycomed, a publicly traded biotechnology company. At Glycomed, Brian concentrated on business development and strategic alliances, closing deals with Eli Lilly & Company, Genentech and Sankyo before leading the sale of Glycomed to Ligand Pharmaceuticals. Prior to this, he co-founded and served as director of Perkin Elmer/Cetus Instruments, a joint venture for robotics automation and genomics research instruments and products later acquired by Perkin Elmer. Under Brian's management, the venture developed and launched the GeneAmp® Polymerase Chain Reaction (PCR) system, the fundamental DNA amplification innovation responsible for fueling the explosive growth of genomics research. Brian received a bachelor's degree in biological sciences from the University of California, Irvine; a master's degree from the University of California, Davis, and an MBA from Harvard Business School.

Steve Bengston is Managing Director of Emerging Company Services (ECS) at PricewaterhouseCoopers. Before joining PwC, Steven had 20 years of experience in a variety of marketing business development and general management roles at several high tech companies in the Bay Area. Most recently, he was Pres/CEO of ynot.com, a leading international emarketing and greeting card company. Previously, he was VP Marketing & Business Development at Worldview Systems, an Internet travel pioneer. At Worldview, Steve helped launch and market Travelocity with Sabre Interactive. Steve has a BA in Economics and MBA from Stanford University. He works closely or sits on the Advisory Board at Time Domain Systems, SDForum, Financing Partners, and the Stanford/MIT Venture Lab, has taught classes on funding/running start ups at UC Berkeley and Stanford, and is active in a variety of other organizations in the Bay Area targeting entrepreneurs and investors.

Mitchell Kertzman is a Partner at Hummer Winblad Venture Partners. He has over 30 years of experience as a CEO of public and private software companies. Most recently, Mitchell was Chairman and CEO of Liberate Technologies, a provider of platform software for the delivery of digital services by cable television companies. Before joining Liberate, he was chairman of the board and CEO of Sybase, Inc. Mitchell was founder and CEO of Powersoft, which merged with Sybase in February 1995. He renamed the company and became a member of the Hummer Winblad family in 1991 when Hummer Winblad invested in the company, which became the leading provider of client-server development tools with its flagship product, PowerBuilder. The merger with Sybase in 1995 was, at the time, the most valuable in the history of the software industry. Mitchell was awarded an honorary doctorate of humane letters from the University of Massachusetts, Lowell. He is currently sits on the Boards of ActiveGrid, Bridgestream, Five9, HubPages, Palamida, PostApp and Sapias.

John Steuart is a Managing Director at Claremont Creek Ventures. He has spent the last 20 years managing, building and investing in technology and life science companies.  John focuses on the intersection of the information technology and life sciences markets including bioinformatics, molecular diagnostics, genomics, proteomics, software and instrumentation for med-tech industries. John serves on the board of directors of Arcxis, PropertyBridge, and Tibion Bionic Technologies.  He is an Industry Fellow at the Center for Entrepreneurship and Technology at the College of Engineering as well as a member of the Advisory Council to the Lester Center's Berkeley Entrepreneurs’ Forum at UC Berkeley.  He recently joined the Advisory Board for Technology Ventures Corporation (TVC), an organization which fosters entrepreneurs and technologies coming out of the national labs such as Lawrence Berkeley, Sandia and Lawrence Livermore. Early in his career, he joined Alafi Capital, an Emeryville-based venture firm specializing in early-stage biomedical companies, where he served as an officer of the General Partner.  At Alafi, John lead investments in more than a dozen successful start-ups, and served as the senior executive and board member of various firms such as Tanox, Software Ventures, Lipomatrix, and Megan Health. In the mid-90s, together with colleague Nat Goldhaber, John helped start Cybergold, an Internet marketing and payments company, serving as the early COO and CFO through its IPO, merger with Mypoints and sale to United Airlines. John continued with the Mypoints unit of United serving as the Senior Vice President of Strategic Partnerships.

Ravi Mhatre is a founding partner of Lightspeed Venture Partners, and primarily focuses on Internet and software investments. He has eleven years of venture capital experience and six years of operating experience. Before joining Weiss, Peck & Greer Venture Partners in 1999, Ravi was with Bessemer Venture Partners, and invested in NetGenesis Software [NTGX], Verio [VRIO], VIA-Networks [VNWI], Webspective Software (acquired by Inktomi) and InCert Software (acquired by Geodesic). Previously, Ravi ran market development efforts for the engineering workstation division of Silicon Graphics, and also worked at Lehman Brothers and Booz Allen Hamilton. He holds a BS in Electrical Engineering, an AB in Economics, and an MBA from Stanford University.

This program has been organized by Fenwick& West and will be moderated by Robert Dellenbach of Fenwick & West.

Robert Dellenbach has counseled entrepreneurs and investors as a corporate and intellectual property attorney at Fenwick & West LLP since 1989. He advises start-ups and venture-backed companies on business plans, incorporation, financing, founders stock, employee equity plans, intellectual property protection, licensing, distribution and strategic agreements, mergers and acquisitions and public offerings. Mr. Dellenbach has represented more than a hundred software, communications, Internet, biotechnology, semiconductor and other technology companies and their investors.

[top of page]